<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD006968-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD006968-sec-0008"></div> <div class="table" id="CD006968-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Chlorhexidine rinse versus placebo/no treatment for the prevention of dry socket</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="" valign="" colspan="7" rowspan="1" class="headercell"> <p><b>Chlorhexidine rinse versus placebo/no treatmentÂ for the prevention of dry socket</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients having a tooth extraction </p> <p><b>Setting:</b> primary or secondary care/home use<br><b>Intervention:</b> chlorhexidine rinse </p> <p><b>Comparison:</b>Â placebo/no treatmentÂ control </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="table-header separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="table-header separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Placebo/no treatmentÂ control</b><sup>b</sup></p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Chlorhexidine rinse</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p><b>Presence of dry socket</b><br>(agreed diagnostic criteria.<br>Followâup: median 7 days)Â  </p> <p>Â </p> </td> <th scope="col" align="" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Study population</b> </p> </th> <td align="" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p><b>OR 0.38</b> </p> <p>(0.25 to 0.58)</p> <p>Â </p> <p>Â </p> </td> <td align="" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>1547</p> <p>(6 studies)Â </p> <p>Â </p> <p>Â </p> <p>Â </p> <p>Â </p> </td> <td align="" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>ââââ<br><b>moderate</b><sup>a</sup></p> <p>Â </p> <p>Â </p> </td> <td align="" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>Â â</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>10 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>4 per 1000</b><br>(3 to 6)Â  </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Moderate</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>50 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>20 per 1000</b><br>(13 to 30) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High</b>Â  </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>300 per 1000</b><br>Â  </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>140 per 1000</b> </p> <p>(97 to 199)</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>3 trials reported no adverse events.Â 1 study reported adverse events (alterations in taste, bad taste, staining) inÂ 24/62 in chlorhexidine group versus 0/40 in placebo group,Â Peto OR = 8.42 (95% CI 3.31 to 21.39).Â A further study reported adverse events (bad taste, stomach upset)Â in 4/40 in chlorhexidine group versus 0/40 in placebo group, Peto OR = 20.87 (95% CI 8.38 to 52.02).Â Another study reported many adverse events in both experimental and placebo groups but only attributes 1 (stomatitis) to use of chlorhexidine </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> confidence interval; <b>OR:</b> odds ratio. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br>Â  </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded once as 3 trials were assessed as being at high risk of bias and 1 at unclear risk of bias.<br><sup>b</sup>The assumed risk values were set to reflect prevalence rates for routine dental extractions (1% and 5%) and for extraction of mandibular third molars (30%). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006968-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Chlorhexidine gel versus placebo/no treatment for the prevention of dry socket</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="" valign="" colspan="7" rowspan="1" class="headercell"> <p><b>Chlorhexidine gel versus placebo/no treatment for the prevention of dry socket</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients having a tooth extraction </p> <p><b>Setting:</b> primary or secondary care/home use<br><b>Intervention:</b> chlorhexidine gel </p> <p><b>Comparison:</b>Â placebo/no treatment control </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="table-header separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk<sup>b</sup></b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="table-header separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Placebo/no treatment control</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Chlorhexidine gel</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p><b>Presence of dry socket</b><br>(agreed diagnostic criteria.<br>Followâup: median 7 days) </p> <p>Â <br>Â <br>Â  </p> </td> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Study population</b> </p> </th> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p><b>OR 0.44Â </b><br>(0.27 to 0.71)Â  </p> <p>Â </p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>753<br>(7 studies)Â  </p> <p>Â </p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>ââââ<br><b>moderate</b><sup>a</sup></p> <p>Â </p> <p>Â </p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>âÂ </p> <p>Â </p> <p>Â </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>10 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>5 per 1000</b><br>(3 to 7) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Moderate</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>50 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>23Â per 1000</b><br>(14Â to 36) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High</b>Â  </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>300 per 1000</b> </p> <p>Â </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>159 per 1000</b> </p> <p>(104 to 234)</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Â No adverse events were reportedÂ </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> confidence interval; <b>OR:</b> odds ratio. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded onceÂ as 2Â trials were assessed as being at low risk of bias, 2 at unclear risk, and the other 3 at high risk of bias.<br><sup>b</sup>The assumed risk values were set to reflect prevalence rates for routine dental extractions (1% and 5%) and for extraction of mandibular third molars (30%). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006968-tbl-0003"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 3.</span>Â <span class="table-title">ChlorhexidineÂ gel versus chlorhexidineÂ rinse for the prevention of dry socket</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="" valign="" colspan="7" rowspan="1" class="headercell"> <p><b>Chlorhexidine gel versus chlorhexidine rinse for the prevention of dry socket</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients having a tooth extraction </p> <p><b>Setting:Â </b>primary or secondary care/home use </p> <p><b>Intervention:</b> chlorhexidine gelÂ  </p> <p><b>Comparison:</b> chlorhexidineÂ rinse </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="table-header separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p>Assumed risk<b><sup>b</sup></b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="table-header separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Chlorhexidine rinse</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Chlorhexidine gel</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p><b>Presence of dry socket</b><br>(agreed diagnostic criteria.<br>Followâup: median 7 days) </p> <p>Â <br>Â <br>Â  </p> </td> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Study population</b> </p> </th> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p><b>RR 0.74Â </b><br>(0.46 to 1.20) </p> <p>Â </p> <p>Â </p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>383<br>(2 studies) </p> <p>Â </p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>ââââ<br><b>low</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>Â âÂ </p> <p>Â </p> <p>Â </p> <p>Â </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>10 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>8 per 1000</b><br>(5 to 12) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Moderate</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>50 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>37 per 1000</b><br>(23 to 60) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High</b>Â  </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>300 per 1000</b> </p> <p>Â </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>222 per 1000</b> </p> <p>(138 to 360)Â </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>Â No adverse events were reportedÂ </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded twice: once for 2Â studies at high risk of bias and once for imprecision of estimate due to the CI including the possibility of a benefit for both treatment groups.Â <br><sup>b</sup>The assumed risk values were set to reflect prevalence rates for routine dental extractions (1% and 5%) and for extraction of mandibular third molars (30%). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006968-tbl-0004"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 4.</span>Â <span class="table-title">Platelet rich plasma versus placebo/no treatment for the prevention of dry socket</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="" valign="" colspan="7" rowspan="1" class="headercell"> <p><b>Platelet rich plasma versus placebo/no treatmentÂ for the prevention of dry socket</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients having a tooth extraction </p> <p><b>Setting:</b> primary or secondary care<br><b>Intervention:</b> platelet rich plasma </p> <p><b>Comparison:Â </b>placebo/no treatment control </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks (95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="table-header separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk<sup>b</sup></b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="table-header separated">
<th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Placebo/no treatmentÂ control</b> </p> </th> <th scope="col" align="" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Platelet rich plasma</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p><b>Presence of dry socket</b><br>(agreed diagnostic criteria.<br>Followâup: median 7 days) </p> <p>Â </p> <p>Â </p> </td> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Study population</b> </p> </th> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p><b>RR 0.51</b> </p> <p>(0.19 to 1.33)</p> <p>Â </p> <p>Â </p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>127</p> <p>(2 studies)Â </p> <p>Â </p> <p>Â </p> <p>Â </p> <p>Â </p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>a</sup></p> <p>Â </p> <p>Â </p> </td> <td align="left" valign="top" colspan="1" rowspan="7" bgcolor="#ffffff"> <p>â</p> <p>Â </p> <p>Â </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Low</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>10 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>6 per 1000</b><br>(2 to 14) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Moderate</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>50 per 1000</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>26 per 1000</b><br>(10 to 67) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>High</b>Â  </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>300 per 1000</b><br>Â  </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>153 per 1000</b> </p> <p>(57 to 399)</p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>No adverse events were reportedÂ </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded 3 times: once for 2Â studies at high risk of bias, once for low event rate, and once for the CI including the possibility of benefit for both treatment groups.<br><sup>b</sup>The assumed risk values were set to reflect prevalence rates for routine dental extractions (1% and 5%) and for extraction of mandibular third molars (30%). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD006968-tbl-0005"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 5.</span>Â <span class="table-title">Zinc oxide eugenol versus Alvogyl for the treatmentÂ of dry socket</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="" valign="" colspan="7" rowspan="1" class="headercell"> <p>Zinc oxide eugenol<b>versus Alvogyl for the treatmentÂ of dry socket</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Population:Â </b>adults with dry socket<br><b>Setting:</b>Â primary and secondary care<br><b>Intervention:</b>Â zinc oxide eugenol </p> <p><b>Comparison:</b>Â Alvogyl </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Relative effect</b><br><b>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Number of participants</b><br><b>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Certainty of the evidence</b><br><b>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="3" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Assumed risk</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Corresponding risk</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Alvogyl</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Zinc oxide eugenol</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Healing</b> </p> </td> <td align="left" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>2 studiesÂ used different healing outcomes and we were unable to combine the data</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Pain</b><br>VAS (0â10) </p> <p>Followâup: 7 days</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The median score in the Alvogyl group was 1.7</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean score in the zinc oxide eugenol group wasÂ 1.04 higher to 1.75 higherÂ </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>â</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>80<br>(2 studies) </p> <p>Â </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low</b><sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>This result was inconsistent with the 5âday dataÂ </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Swelling</b> </p> </td> <td align="left" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>No studies reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Limitation of chewing or swallowing</b> </p> </td> <td align="left" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>No studies reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Fever</b> </p> </td> <td align="left" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>No studies reported this outcome</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse effects</b> </p> </td> <td align="left" valign="top" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>1 study (<a href="./references#CD006968-bbs2-0041">Supe 2018</a>) reported 2 patients (8%) in the Alvogyl group and 9 patients (36%) in the zinc oxide eugenol group had delayed healing, classed as nonâhealed sockets after 10 daysÂ  </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for theÂ <b>assumed risk</b>Â is median score. TheÂ <b>corresponding risk</b>Â (and its 95% CI) is based on the assumed risk in the comparison group and theÂ <b>relative effect</b>Â of the intervention (and its 95% CI).<br><b>CI:Â </b>confidence interval. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b>Â we are very confident that the true effect lies close to that of the estimate of the effect.<br><b>Moderate certainty:</b>Â we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br><b>Low certainty:</b>Â our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br><b>Very low certainty:</b>Â we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded 3 timesÂ as 2 studies at unclear risk of bias, heterogeneity,Â and differences in the results for day 5 versus day 7. Â  </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
